PropertyValue
?:abstract
  • COVID‐19 disease is a highly contagious and particularly popular problem in all countries. A variety of repurposed drugs and investigational drugs such as remdesivir, chloroquine, hydroxychloroquine, ritonavir, lopinavir, interferon‐beta, and other potential drugs have been studied for COVID19 treatment. We reviewed the potential dermatological side‐effects of these drugs.
?:creator
?:doi
  • 10.1111/dth.13476
?:doi
?:journal
  • Dermatol_Ther
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/87ae992ff24eac27487e562d02f5b29ff65d89f7.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7262017.xml.json
?:pmcid
?:pmid
?:pmid
  • 32358890.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Cutaneous sıde‐effects of the potential COVID‐19 drugs
?:type
?:year
  • 2020-05-22

Metadata

Anon_0  
expand all